Infectious Diseases
Infectious Diseases 2
Tala R. Nasr Brack, MD (she/her/hers)
Neonatologist
Baylor University Medical Center/ Pediatrix
Dallas, Texas, United States
We included 842,928 infants discharged over the study period. Between 2011 and 2020 the prevalence of CS increased from 0.8 to 4.6 per 1000 infants (P< 0.05). Mortality (~1% of all infants with CS) and many of the clinical characteristics remained stable over the decade.
Maternal co-infection with Hepatitis C increased from 2.3% to 5.2% and maternal drug use of infants born with CS increased from 6.1% to 24.6% between 2011-2012 and 2019-2020. Most infants were treated with PCN for 10 days and median length of stay was 10 days.